References
- 1BurkhardPRAcute and subacute drug-induced movement disordersParkinsonism Relat Disord201420S108112doi: 10.1016/S1353-8020(13)70027-024262159
- 2BarnesTREThe Barnes Akathisia Rating Scale—revisitedJ Psychopharmacol200317365370doi: 10.1177/026988110317401314870947
- 3DonaldsonIMarsdenCDSchneiderSBhatiaKMarsden’s book of movement disorders Vol. 1OxfordOxford University Press2012
- 4LohrJBEidtCAAbdulrazzaq AlfarajASolimanMAThe clinical challenges of akathisiaCNS Spectr201520(Suppl. 1)114doi: 10.1017/S1092852915000838
- 5StewartJTAkathisia following traumatic brain injury: treatment with bromocriptineJ Neurol Neurosurg Psychiatry19895212001201doi: 10.1136/jnnp.52.10.12002795050
- 6CarrazanaERossitchEMartinezJUnilateral “akathisia” in a patient with AIDS and a toxoplasmosis subthalamic abscessNeurology198939449450doi: 10.1212/WNL.39.3.4492927662
- 7KulogluMAtmacaMUstündagBCanatanHGeciciOTezcanESerum iron levels in schizophrenic patients with or without akathisiaEur Neuropsychopharmacol2003136771doi: 10.1016/S0924-977X(02)00073-112650948
- 8AshkenaziRBen-ShacharDYoudimMBNutritional iron and dopamine binding sites in the rat brainPharmacol Biochem Behav198217(Suppl. 1)4347doi: 10.1016/0091-3057(82)90509-3
- 9CaroffSNCampbellECDrug-Induced extrapyramidal syndromes: implications for contemporary practicePsychiatr Clin North Am201639391411doi: 10.1016/j.psc.2016.04.00327514296
- 10HermeshHMunitzHUnilateral neuroleptic-induced akathisiaClin Neuropharmacol199013253258http://www.ncbi.nlm.nih.gov/pubmed/1972654doi: 10.1097/00002826-199006000-000091972654
